Insmed (INSM) Net Margin (2010 - 2026)
Insmed (INSM) recorded quarterly Net Margin of 53.46% in Q1 2026, up 57.06% quarter-over-quarter from 124.5% in Q4 2025, and up 22296.0% on a YoY basis from N/an in Q1 2025.
Insmed (INSM) Net Margin (2010 - 2026) Analysis & Trends
Insmed's Net Margin history runs 12 years deep, the most recent figure standing at 53.46% for Q1 2026.
- In Q1 2026, Net Margin rose 22296.0% year-over-year to 53.46%; the TTM figure through Mar 2026 stood at 144.44% (up 12149.0% YoY), while the FY2025 annual figure was 210.54%, up 4070.0% from the prior year.
- Net Margin was 53.46% for Q1 2026 at Insmed, up from 124.5% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 53.46% in Q1 2026 to a low of 332.75% in Q2 2024.
- Historically, Net Margin has averaged 222.94% across 5 years, with a median of 225.53% in 2024.
- The sharpest annual moves came in 2023 and 2026: Net Margin plunged 17034 bps in 2023, then surged 22296 bps in 2026.
- A 5-year view of Net Margin shows it stood at 270.02% in 2022, then gained by 18 bps to 222.31% in 2023, then declined by 1 bps to 225.53% in 2024, then jumped by 45 bps to 124.5% in 2025, then jumped by 57 bps to 53.46% in 2026.
- The last three Net Margin figures came in at 53.46% (Q1 2026), 124.5% (Q4 2025), and 259.95% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.82% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | -53.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.46% |
| Dec 31, 2025 | -124.50% |
| Sep 30, 2025 | -259.95% |
| Jun 30, 2025 | -299.48% |
| Mar 31, 2025 | -276.42% |
| Dec 31, 2024 | -225.53% |
| Sep 30, 2024 | -236.04% |
| Jun 30, 2024 | -332.75% |
| Mar 31, 2024 | -208.07% |
| Dec 31, 2023 | -222.31% |
| Sep 30, 2023 | -201.00% |
| Jun 30, 2023 | -316.99% |
| Mar 31, 2023 | -244.98% |
| Dec 31, 2022 | -270.02% |
| Sep 30, 2022 | -193.63% |
| Jun 30, 2022 | -146.65% |
| Mar 31, 2022 | -178.17% |
| Dec 31, 2021 | -201.30% |
| Sep 30, 2021 | -241.06% |
| Jun 30, 2021 | -258.61% |